Officer Dennis Cho Files Intent to Sell $1.27M in Twist Bioscience Stock
TWST has more than doubled off its 52-week low of $23.3.
Summary
Twist Bioscience Officer Dennis Cho has filed an intent to sell approximately $1.27 million worth of company stock, continuing a pattern of insider sales while the stock trades near its 52-week high.
Key Events · Ownership and Investor Activity · TWST
-
Officer Files Intent to Sell
Officer Dennis Cho has filed a Form 144 indicating an intent to sell 14,205 shares of Twist Bioscience common stock, valued at approximately $1,274,898.75.
-
Continuation of Insider Selling Trend
This filing follows a series of Form 144 filings by officers, including Dennis Cho, over the past 90 days, contributing to a net insider distribution of over $10.5 million.
-
Stock Trading Near 52-Week High
The proposed sale occurs while Twist Bioscience stock is trading near its 52-week high, suggesting insiders are capitalizing on recent price appreciation.
-
Shares Acquired via Vesting
The shares intended for sale were primarily acquired through restricted stock vesting, indicating they are compensation-related.
Analysis · TWST · Life Sciences
This Form 144 filing indicates an officer's intent to sell a significant amount of company stock, adding to a recent pattern of insider distribution. The proposed sale of over $1.27 million, while not a massive percentage of the company's market cap, is notable given the stock is trading near its 52-week high. This suggests insiders are taking profits, which can be interpreted negatively by the market, especially when combined with the company's recent ATM offering.
How filings like this one have moved
In the 30 days to Oct 25, 2026, 29.7% of the 1433 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.14%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TWST was trading at $91.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.7B. The 52-week trading range was $23.30 to $93.80. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.